Clinical Evidence From Randomized Controlled Trials:中医治疗冠状动脉疾病

2021-09-26 August MedSci原创

近年来,由于各种原因,诸如人口老龄化,心血管疾病的数量急剧上升。与心血管疾病相关的死亡率也在全球范围内迅速上升,给全球健康带来了巨大威胁。

在美国,冠状动脉疾病(CAD)占所有心血管疾病的三分之二以上,几乎一半的美国人至少有一个危险因素。在欧洲,与高收入国家相比,中等收入国家的心血管死亡率更高,在这些国家中,心血管死亡率在潜在生命损失年数中所占的比例更大。亚洲国家的情况并不比西方国家好。大多数亚洲国家都在经历 CAD 的挑战。根据最新的临床实践指南,CAD常主要分为稳定型CAD(SCAD,即慢性心肌缺血综合征)和急性冠脉综合征,治疗以生活方式管理、药物治疗(包括常规西医药物和中药)和血运重建。尽管使用了药物治疗和血运重建,但仍有很大的提高疗效和减少不良反应的空间。

中国传统医药(TCM),已经显示出在预防,治疗效果,恢复其独特的优势。中医药循证应用在中国和亚洲其他国家都站稳脚跟,随着中医药在东方的普及,也越来越被世界其他国家接受和使用。迄今为止,越来越多的随机对照试验(RCTs)被认为是测试广泛疾病治疗的疗效和安全性的黄金标准,并为制定治疗指南(20)提供了关于中医药治疗冠心病的指南。这些可靠的结果不仅推动了中医现代化,也让我们对CAD的管理更有信心。然而,不得不承认,中医的RCTs开展相对较晚,这些RCTs使用替代终点,样本量小,随访时间短,结果多样。在这里利用来自 RCT 的现有证据,批判性地评估了中医对 CAD 患者的疗效和安全性。

主要随机对照试验的详细信息:

中医药是中华民族的大宝库,针对包括冠心病在内的各种疾病的循证医学也在不断探索中。这里系统地回顾了17项 RCT,共包括 11,726 名患者,以重新评估中医治疗 CAD 的有效性和安全性。样本量从 59 到 4,870 名参与者不等,平均随访时间从 2 周到 4.5 年不等。使用改良的 Jadad 评分量表评估试验的质量,如前所述,发现在 17 个 RCT 中,9 个 RCT (52.94%) 获得满分 7,只有 3 个 RCT (17.65%)被认定为低质量试验,因为低于三分(表格1)。在大多数 RCT 中,TCM 与稳定型心绞痛、不稳定型心绞痛、MI、SCAD 和冠状动脉旁路移植术的替代终点显着改善相关。然而,只有五项试验(29.41%)具体描述了硬终点,只有一项试验(5.88%)没有报告安全性。一项涉及 100 名 CAD 患者的 RCT 证明丹参(丹参)和葛根辅助治疗有效地改善了血管功能和结构,并且耐受性良好,表明它们可能成为一种新的二级预防方法。有趣的是,除了丹参和葛根,随机对照试验表明芪参益气滴丸和通心络胶囊也可作为MI二级预防的补充和替代疗法。总体而言,与模拟药物、安慰剂或西药相比,中医药在 CAD 的预防、治疗和保健方面具有显着的有效性和安全性。

中医在冠状动脉疾病中的防护作用:

总之,结果表明,中医药可能是 CAD 患者一级和二级预防的补充和替代药物。因此,建议至少在一定程度上为 CAD 开中药处方,尤其是在选定的人群中。然而,需要进一步严格设计的试验来评估中医对 CAD 患者长期硬终点的影响。

原文:Liang B, Gu N. Traditional Chinese Medicine for Coronary Artery Disease Treatment: Clinical Evidence From Randomized Controlled Trials. Front Cardiovasc Med. 2021;8:702110. Published 2021 Aug 6. doi:10.3389/fcvm.2021.702110

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1783622, encodeId=09221e83622ab, content=<a href='/topic/show?id=74665080c1' target=_blank style='color:#2F92EE;'>#controlled#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5080, encryptionId=74665080c1, topicName=controlled)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Tue Jul 19 19:51:46 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2056949, encodeId=e992205694909, content=<a href='/topic/show?id=bcb11e80913' target=_blank style='color:#2F92EE;'>#trials#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17809, encryptionId=bcb11e80913, topicName=trials)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ba8129, createdName=zhzhxiang, createdTime=Sun Apr 10 08:51:46 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005892, encodeId=9770200589252, content=<a href='/topic/show?id=293a10e89bd' target=_blank style='color:#2F92EE;'>#LED#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10789, encryptionId=293a10e89bd, topicName=LED)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK17mLkWpia3T92NlEWTkEhrhZa7XPNic2JqQumEicZXGYFG6Ww5SCIl0Uq62bhhPnibAqIZDHtRva92A/132, createdBy=e0752500025, createdName=江川靖瑶, createdTime=Sun Dec 26 00:51:46 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252960, encodeId=91331252960c1, content=<a href='/topic/show?id=463230886b8' target=_blank style='color:#2F92EE;'>#冠状动脉疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30886, encryptionId=463230886b8, topicName=冠状动脉疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Tue Sep 28 07:51:46 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500903, encodeId=390d1500903bb, content=<a href='/topic/show?id=454821463f0' target=_blank style='color:#2F92EE;'>#中医治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21463, encryptionId=454821463f0, topicName=中医治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a33a9470844, createdName=天堂的云, createdTime=Tue Sep 28 07:51:46 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507790, encodeId=10f5150e790fa, content=<a href='/topic/show?id=8764484014' target=_blank style='color:#2F92EE;'>#clinical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4840, encryptionId=8764484014, topicName=clinical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ee59933733, createdName=zll0628, createdTime=Tue Sep 28 07:51:46 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1631329, encodeId=00fa16313293d, content=<a href='/topic/show?id=ae581e80805' target=_blank style='color:#2F92EE;'>#Trial#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17808, encryptionId=ae581e80805, topicName=Trial)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1ad21715548, createdName=feifers, createdTime=Tue Sep 28 07:51:46 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055071, encodeId=e90110550e153, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/20274508595745adb221d4af84f71a30/44cac845ab1e4a3a81ff3fe6373b97b0.jpg, createdBy=2a601767050, createdName=Mongolian, createdTime=Sun Sep 26 19:11:57 CST 2021, time=2021-09-26, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1783622, encodeId=09221e83622ab, content=<a href='/topic/show?id=74665080c1' target=_blank style='color:#2F92EE;'>#controlled#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5080, encryptionId=74665080c1, topicName=controlled)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Tue Jul 19 19:51:46 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2056949, encodeId=e992205694909, content=<a href='/topic/show?id=bcb11e80913' target=_blank style='color:#2F92EE;'>#trials#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17809, encryptionId=bcb11e80913, topicName=trials)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ba8129, createdName=zhzhxiang, createdTime=Sun Apr 10 08:51:46 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005892, encodeId=9770200589252, content=<a href='/topic/show?id=293a10e89bd' target=_blank style='color:#2F92EE;'>#LED#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10789, encryptionId=293a10e89bd, topicName=LED)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK17mLkWpia3T92NlEWTkEhrhZa7XPNic2JqQumEicZXGYFG6Ww5SCIl0Uq62bhhPnibAqIZDHtRva92A/132, createdBy=e0752500025, createdName=江川靖瑶, createdTime=Sun Dec 26 00:51:46 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252960, encodeId=91331252960c1, content=<a href='/topic/show?id=463230886b8' target=_blank style='color:#2F92EE;'>#冠状动脉疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30886, encryptionId=463230886b8, topicName=冠状动脉疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Tue Sep 28 07:51:46 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500903, encodeId=390d1500903bb, content=<a href='/topic/show?id=454821463f0' target=_blank style='color:#2F92EE;'>#中医治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21463, encryptionId=454821463f0, topicName=中医治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a33a9470844, createdName=天堂的云, createdTime=Tue Sep 28 07:51:46 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507790, encodeId=10f5150e790fa, content=<a href='/topic/show?id=8764484014' target=_blank style='color:#2F92EE;'>#clinical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4840, encryptionId=8764484014, topicName=clinical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ee59933733, createdName=zll0628, createdTime=Tue Sep 28 07:51:46 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1631329, encodeId=00fa16313293d, content=<a href='/topic/show?id=ae581e80805' target=_blank style='color:#2F92EE;'>#Trial#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17808, encryptionId=ae581e80805, topicName=Trial)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1ad21715548, createdName=feifers, createdTime=Tue Sep 28 07:51:46 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055071, encodeId=e90110550e153, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/20274508595745adb221d4af84f71a30/44cac845ab1e4a3a81ff3fe6373b97b0.jpg, createdBy=2a601767050, createdName=Mongolian, createdTime=Sun Sep 26 19:11:57 CST 2021, time=2021-09-26, status=1, ipAttribution=)]
    2022-04-10 zhzhxiang
  3. [GetPortalCommentsPageByObjectIdResponse(id=1783622, encodeId=09221e83622ab, content=<a href='/topic/show?id=74665080c1' target=_blank style='color:#2F92EE;'>#controlled#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5080, encryptionId=74665080c1, topicName=controlled)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Tue Jul 19 19:51:46 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2056949, encodeId=e992205694909, content=<a href='/topic/show?id=bcb11e80913' target=_blank style='color:#2F92EE;'>#trials#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17809, encryptionId=bcb11e80913, topicName=trials)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ba8129, createdName=zhzhxiang, createdTime=Sun Apr 10 08:51:46 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005892, encodeId=9770200589252, content=<a href='/topic/show?id=293a10e89bd' target=_blank style='color:#2F92EE;'>#LED#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10789, encryptionId=293a10e89bd, topicName=LED)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK17mLkWpia3T92NlEWTkEhrhZa7XPNic2JqQumEicZXGYFG6Ww5SCIl0Uq62bhhPnibAqIZDHtRva92A/132, createdBy=e0752500025, createdName=江川靖瑶, createdTime=Sun Dec 26 00:51:46 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252960, encodeId=91331252960c1, content=<a href='/topic/show?id=463230886b8' target=_blank style='color:#2F92EE;'>#冠状动脉疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30886, encryptionId=463230886b8, topicName=冠状动脉疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Tue Sep 28 07:51:46 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500903, encodeId=390d1500903bb, content=<a href='/topic/show?id=454821463f0' target=_blank style='color:#2F92EE;'>#中医治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21463, encryptionId=454821463f0, topicName=中医治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a33a9470844, createdName=天堂的云, createdTime=Tue Sep 28 07:51:46 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507790, encodeId=10f5150e790fa, content=<a href='/topic/show?id=8764484014' target=_blank style='color:#2F92EE;'>#clinical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4840, encryptionId=8764484014, topicName=clinical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ee59933733, createdName=zll0628, createdTime=Tue Sep 28 07:51:46 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1631329, encodeId=00fa16313293d, content=<a href='/topic/show?id=ae581e80805' target=_blank style='color:#2F92EE;'>#Trial#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17808, encryptionId=ae581e80805, topicName=Trial)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1ad21715548, createdName=feifers, createdTime=Tue Sep 28 07:51:46 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055071, encodeId=e90110550e153, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/20274508595745adb221d4af84f71a30/44cac845ab1e4a3a81ff3fe6373b97b0.jpg, createdBy=2a601767050, createdName=Mongolian, createdTime=Sun Sep 26 19:11:57 CST 2021, time=2021-09-26, status=1, ipAttribution=)]
    2021-12-26 江川靖瑶
  4. [GetPortalCommentsPageByObjectIdResponse(id=1783622, encodeId=09221e83622ab, content=<a href='/topic/show?id=74665080c1' target=_blank style='color:#2F92EE;'>#controlled#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5080, encryptionId=74665080c1, topicName=controlled)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Tue Jul 19 19:51:46 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2056949, encodeId=e992205694909, content=<a href='/topic/show?id=bcb11e80913' target=_blank style='color:#2F92EE;'>#trials#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17809, encryptionId=bcb11e80913, topicName=trials)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ba8129, createdName=zhzhxiang, createdTime=Sun Apr 10 08:51:46 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005892, encodeId=9770200589252, content=<a href='/topic/show?id=293a10e89bd' target=_blank style='color:#2F92EE;'>#LED#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10789, encryptionId=293a10e89bd, topicName=LED)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK17mLkWpia3T92NlEWTkEhrhZa7XPNic2JqQumEicZXGYFG6Ww5SCIl0Uq62bhhPnibAqIZDHtRva92A/132, createdBy=e0752500025, createdName=江川靖瑶, createdTime=Sun Dec 26 00:51:46 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252960, encodeId=91331252960c1, content=<a href='/topic/show?id=463230886b8' target=_blank style='color:#2F92EE;'>#冠状动脉疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30886, encryptionId=463230886b8, topicName=冠状动脉疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Tue Sep 28 07:51:46 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500903, encodeId=390d1500903bb, content=<a href='/topic/show?id=454821463f0' target=_blank style='color:#2F92EE;'>#中医治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21463, encryptionId=454821463f0, topicName=中医治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a33a9470844, createdName=天堂的云, createdTime=Tue Sep 28 07:51:46 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507790, encodeId=10f5150e790fa, content=<a href='/topic/show?id=8764484014' target=_blank style='color:#2F92EE;'>#clinical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4840, encryptionId=8764484014, topicName=clinical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ee59933733, createdName=zll0628, createdTime=Tue Sep 28 07:51:46 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1631329, encodeId=00fa16313293d, content=<a href='/topic/show?id=ae581e80805' target=_blank style='color:#2F92EE;'>#Trial#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17808, encryptionId=ae581e80805, topicName=Trial)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1ad21715548, createdName=feifers, createdTime=Tue Sep 28 07:51:46 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055071, encodeId=e90110550e153, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/20274508595745adb221d4af84f71a30/44cac845ab1e4a3a81ff3fe6373b97b0.jpg, createdBy=2a601767050, createdName=Mongolian, createdTime=Sun Sep 26 19:11:57 CST 2021, time=2021-09-26, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1783622, encodeId=09221e83622ab, content=<a href='/topic/show?id=74665080c1' target=_blank style='color:#2F92EE;'>#controlled#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5080, encryptionId=74665080c1, topicName=controlled)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Tue Jul 19 19:51:46 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2056949, encodeId=e992205694909, content=<a href='/topic/show?id=bcb11e80913' target=_blank style='color:#2F92EE;'>#trials#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17809, encryptionId=bcb11e80913, topicName=trials)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ba8129, createdName=zhzhxiang, createdTime=Sun Apr 10 08:51:46 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005892, encodeId=9770200589252, content=<a href='/topic/show?id=293a10e89bd' target=_blank style='color:#2F92EE;'>#LED#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10789, encryptionId=293a10e89bd, topicName=LED)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK17mLkWpia3T92NlEWTkEhrhZa7XPNic2JqQumEicZXGYFG6Ww5SCIl0Uq62bhhPnibAqIZDHtRva92A/132, createdBy=e0752500025, createdName=江川靖瑶, createdTime=Sun Dec 26 00:51:46 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252960, encodeId=91331252960c1, content=<a href='/topic/show?id=463230886b8' target=_blank style='color:#2F92EE;'>#冠状动脉疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30886, encryptionId=463230886b8, topicName=冠状动脉疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Tue Sep 28 07:51:46 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500903, encodeId=390d1500903bb, content=<a href='/topic/show?id=454821463f0' target=_blank style='color:#2F92EE;'>#中医治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21463, encryptionId=454821463f0, topicName=中医治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a33a9470844, createdName=天堂的云, createdTime=Tue Sep 28 07:51:46 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507790, encodeId=10f5150e790fa, content=<a href='/topic/show?id=8764484014' target=_blank style='color:#2F92EE;'>#clinical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4840, encryptionId=8764484014, topicName=clinical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ee59933733, createdName=zll0628, createdTime=Tue Sep 28 07:51:46 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1631329, encodeId=00fa16313293d, content=<a href='/topic/show?id=ae581e80805' target=_blank style='color:#2F92EE;'>#Trial#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17808, encryptionId=ae581e80805, topicName=Trial)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1ad21715548, createdName=feifers, createdTime=Tue Sep 28 07:51:46 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055071, encodeId=e90110550e153, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/20274508595745adb221d4af84f71a30/44cac845ab1e4a3a81ff3fe6373b97b0.jpg, createdBy=2a601767050, createdName=Mongolian, createdTime=Sun Sep 26 19:11:57 CST 2021, time=2021-09-26, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1783622, encodeId=09221e83622ab, content=<a href='/topic/show?id=74665080c1' target=_blank style='color:#2F92EE;'>#controlled#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5080, encryptionId=74665080c1, topicName=controlled)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Tue Jul 19 19:51:46 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2056949, encodeId=e992205694909, content=<a href='/topic/show?id=bcb11e80913' target=_blank style='color:#2F92EE;'>#trials#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17809, encryptionId=bcb11e80913, topicName=trials)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ba8129, createdName=zhzhxiang, createdTime=Sun Apr 10 08:51:46 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005892, encodeId=9770200589252, content=<a href='/topic/show?id=293a10e89bd' target=_blank style='color:#2F92EE;'>#LED#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10789, encryptionId=293a10e89bd, topicName=LED)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK17mLkWpia3T92NlEWTkEhrhZa7XPNic2JqQumEicZXGYFG6Ww5SCIl0Uq62bhhPnibAqIZDHtRva92A/132, createdBy=e0752500025, createdName=江川靖瑶, createdTime=Sun Dec 26 00:51:46 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252960, encodeId=91331252960c1, content=<a href='/topic/show?id=463230886b8' target=_blank style='color:#2F92EE;'>#冠状动脉疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30886, encryptionId=463230886b8, topicName=冠状动脉疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Tue Sep 28 07:51:46 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500903, encodeId=390d1500903bb, content=<a href='/topic/show?id=454821463f0' target=_blank style='color:#2F92EE;'>#中医治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21463, encryptionId=454821463f0, topicName=中医治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a33a9470844, createdName=天堂的云, createdTime=Tue Sep 28 07:51:46 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507790, encodeId=10f5150e790fa, content=<a href='/topic/show?id=8764484014' target=_blank style='color:#2F92EE;'>#clinical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4840, encryptionId=8764484014, topicName=clinical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ee59933733, createdName=zll0628, createdTime=Tue Sep 28 07:51:46 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1631329, encodeId=00fa16313293d, content=<a href='/topic/show?id=ae581e80805' target=_blank style='color:#2F92EE;'>#Trial#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17808, encryptionId=ae581e80805, topicName=Trial)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1ad21715548, createdName=feifers, createdTime=Tue Sep 28 07:51:46 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055071, encodeId=e90110550e153, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/20274508595745adb221d4af84f71a30/44cac845ab1e4a3a81ff3fe6373b97b0.jpg, createdBy=2a601767050, createdName=Mongolian, createdTime=Sun Sep 26 19:11:57 CST 2021, time=2021-09-26, status=1, ipAttribution=)]
    2021-09-28 zll0628
  7. [GetPortalCommentsPageByObjectIdResponse(id=1783622, encodeId=09221e83622ab, content=<a href='/topic/show?id=74665080c1' target=_blank style='color:#2F92EE;'>#controlled#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5080, encryptionId=74665080c1, topicName=controlled)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Tue Jul 19 19:51:46 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2056949, encodeId=e992205694909, content=<a href='/topic/show?id=bcb11e80913' target=_blank style='color:#2F92EE;'>#trials#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17809, encryptionId=bcb11e80913, topicName=trials)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ba8129, createdName=zhzhxiang, createdTime=Sun Apr 10 08:51:46 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005892, encodeId=9770200589252, content=<a href='/topic/show?id=293a10e89bd' target=_blank style='color:#2F92EE;'>#LED#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10789, encryptionId=293a10e89bd, topicName=LED)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK17mLkWpia3T92NlEWTkEhrhZa7XPNic2JqQumEicZXGYFG6Ww5SCIl0Uq62bhhPnibAqIZDHtRva92A/132, createdBy=e0752500025, createdName=江川靖瑶, createdTime=Sun Dec 26 00:51:46 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252960, encodeId=91331252960c1, content=<a href='/topic/show?id=463230886b8' target=_blank style='color:#2F92EE;'>#冠状动脉疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30886, encryptionId=463230886b8, topicName=冠状动脉疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Tue Sep 28 07:51:46 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500903, encodeId=390d1500903bb, content=<a href='/topic/show?id=454821463f0' target=_blank style='color:#2F92EE;'>#中医治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21463, encryptionId=454821463f0, topicName=中医治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a33a9470844, createdName=天堂的云, createdTime=Tue Sep 28 07:51:46 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507790, encodeId=10f5150e790fa, content=<a href='/topic/show?id=8764484014' target=_blank style='color:#2F92EE;'>#clinical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4840, encryptionId=8764484014, topicName=clinical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ee59933733, createdName=zll0628, createdTime=Tue Sep 28 07:51:46 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1631329, encodeId=00fa16313293d, content=<a href='/topic/show?id=ae581e80805' target=_blank style='color:#2F92EE;'>#Trial#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17808, encryptionId=ae581e80805, topicName=Trial)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1ad21715548, createdName=feifers, createdTime=Tue Sep 28 07:51:46 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055071, encodeId=e90110550e153, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/20274508595745adb221d4af84f71a30/44cac845ab1e4a3a81ff3fe6373b97b0.jpg, createdBy=2a601767050, createdName=Mongolian, createdTime=Sun Sep 26 19:11:57 CST 2021, time=2021-09-26, status=1, ipAttribution=)]
    2021-09-28 feifers
  8. [GetPortalCommentsPageByObjectIdResponse(id=1783622, encodeId=09221e83622ab, content=<a href='/topic/show?id=74665080c1' target=_blank style='color:#2F92EE;'>#controlled#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5080, encryptionId=74665080c1, topicName=controlled)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Tue Jul 19 19:51:46 CST 2022, time=2022-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2056949, encodeId=e992205694909, content=<a href='/topic/show?id=bcb11e80913' target=_blank style='color:#2F92EE;'>#trials#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17809, encryptionId=bcb11e80913, topicName=trials)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ba8129, createdName=zhzhxiang, createdTime=Sun Apr 10 08:51:46 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005892, encodeId=9770200589252, content=<a href='/topic/show?id=293a10e89bd' target=_blank style='color:#2F92EE;'>#LED#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10789, encryptionId=293a10e89bd, topicName=LED)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK17mLkWpia3T92NlEWTkEhrhZa7XPNic2JqQumEicZXGYFG6Ww5SCIl0Uq62bhhPnibAqIZDHtRva92A/132, createdBy=e0752500025, createdName=江川靖瑶, createdTime=Sun Dec 26 00:51:46 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252960, encodeId=91331252960c1, content=<a href='/topic/show?id=463230886b8' target=_blank style='color:#2F92EE;'>#冠状动脉疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30886, encryptionId=463230886b8, topicName=冠状动脉疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Tue Sep 28 07:51:46 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500903, encodeId=390d1500903bb, content=<a href='/topic/show?id=454821463f0' target=_blank style='color:#2F92EE;'>#中医治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21463, encryptionId=454821463f0, topicName=中医治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a33a9470844, createdName=天堂的云, createdTime=Tue Sep 28 07:51:46 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507790, encodeId=10f5150e790fa, content=<a href='/topic/show?id=8764484014' target=_blank style='color:#2F92EE;'>#clinical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4840, encryptionId=8764484014, topicName=clinical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ee59933733, createdName=zll0628, createdTime=Tue Sep 28 07:51:46 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1631329, encodeId=00fa16313293d, content=<a href='/topic/show?id=ae581e80805' target=_blank style='color:#2F92EE;'>#Trial#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17808, encryptionId=ae581e80805, topicName=Trial)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1ad21715548, createdName=feifers, createdTime=Tue Sep 28 07:51:46 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055071, encodeId=e90110550e153, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/20274508595745adb221d4af84f71a30/44cac845ab1e4a3a81ff3fe6373b97b0.jpg, createdBy=2a601767050, createdName=Mongolian, createdTime=Sun Sep 26 19:11:57 CST 2021, time=2021-09-26, status=1, ipAttribution=)]
    2021-09-26 Mongolian

    学习学习

    0

相关资讯

Sci Signal:中药蛇床子登上Science子刊封面,我国学者证实蛇床子可舒张气道、抑制哮喘,并解析其分子机制

气道高反应性是指气道对多种刺激因子出现过强或过早的收缩反应,这一症状在哮喘病人中尤为常见,严重时可导致病人呼吸困难。常规使用的肾上腺素受体激动剂虽可有效抑制气道高反应性,但容易产生耐药反应。

Medicine:参附强心丸治疗慢性心力衰竭的疗效及安全性

心力衰竭(HF)是各种心脏疾病的终末阶段,预后不良。中医、西医综合疗法一直被认为是慢性心力衰竭(CHF)的一种前瞻性治疗策略。目前已有小规模临床试验和实验研究证明参附强心丸(SFQX)治疗CHF的疗效

金匮肾气丸、六味地黄丸、右归丸,肾虚应该如何选择?一文讲清楚

金匮肾气丸、六味地黄丸、右归丸都是补肾益气的良药,各自的成分和适应症都有所不同。虽然对身体都有益,但毕竟是药,健康人群不需服用。即使是有疾病的人群,在痊愈后也应停止服用。

Circulation:中药天麻-钩藤颗粒有效治疗隐匿性高血压!

虽然,众所周知,隐匿性高血压与心血管预后不良相关,但目前仍无关于隐匿性高血压治疗的随机试验。本研究是一项随机、安慰剂为对照的临床试验,旨在研究隐匿性高血压患者采用中药天麻-钩藤颗粒降血压(BP)治疗的

Biomed Pharmacother:中医药联合肺部给药系统防治特发性肺纤维化可行性探讨

特发性肺纤维化 (IPF) 是一种病因不明的进行性肺间质炎性疾病,也是冠状病毒病重症患者的后遗症。中医药作为一种独特的医学疗法,通过多层次、多靶点的方法,在全球范围内逐渐发挥其在IPF治疗中的优势。

中医药防治大肠癌得新突破:曙光医院李琦教授团队采用中医药降低了大肠癌术后转移率

李琦教授团队证实中药复方可有效预防III期大肠癌术后复发转移,提高患者无病生存期,改善生活质量